Larry M Karnitz, PhD

Professor, Rochester, MN, Oncology

Emailkarnitz.larry@mayo.edu

Source: Scopus
Calculated based on no. of publications stored in Pure and citations from Scopus

Research activity per year

If you made any changes in Pure these will be visible here soon.

Fingerprint

Dive into the research topics where Larry M Karnitz is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

6 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots.

1 Not started
1 Active
5 Finished

Predoctoral Training Program in Molecular Pharmacology
Karnitz, L. M., Ames, M., Kinney, L., Kinney, L. & Kinney, L.
National Institute of General Medical Sciences
8/10/05 → 6/30/21
Project: Research project
IDENTIFICATION OF PROTEINS WHICH INTERACT WITH ADR1
Karnitz, L. M.
National Institutes of Health
Project: Research project
CDK12 in Ovarian Cancer
Karnitz, L. M.
National Cancer Institute
12/1/15 → 11/30/20
Project: Research project
Targeting Chk1 in Acute Myeloid Leukemia
Karnitz, L. M.
National Cancer Institute
7/24/15 → 6/30/20
Project: Research project
Therapeutic targeting of HSP90-dependent signaling
Karnitz, L. M. & Kinney, L.
National Cancer Institute
4/1/04 → 2/28/10
Project: Research project

6911 Citations
41 Scopus h-Index
68 Article
4 Review article
1 Editorial

BRCA1 deficiency upregulates NNMT, which reprograms metabolism and sensitizes ovarian cancer cells to mitochondrial metabolic targeting agents
Kanakkanthara, A., Kurmi, K., Ekstrom, T. L., Hou, X., Purfeerst, E. R., Heinzen, E. P., Correia, C., Huntoon, C. J., O'Brien, D., Wahner Hendrickson, A. E., Dowdy, S. C., Li, H., Oberg, A. L., Hitosugi, T., Kaufmann, S. H., Weroha, S. J. & Karnitz, L. M., Dec 1 2019, In: Cancer research. 79, 23, p. 5920-5929 10 p.
Research output: Contribution to journal › Article › peer-review
10 Scopus citations
Effect of CHK1 Inhibition on CPX-351 Cytotoxicity in vitro and ex vivo
Vincelette, N. D., Ding, H., Huehls, A. M., Flatten, K. S., Kelly, R. L., Kohorst, M. A., Webster, J., Hess, A. D., Pratz, K. W., Karnitz, L. M. & Kaufmann, S. H., Dec 1 2019, In: Scientific reports. 9, 1, 3617.
Research output: Contribution to journal › Article › peer-review

Open Access
2 Scopus citations
Carnitine Palmitoyltransferase 1A Has a Lysine Succinyltransferase Activity
Kurmi, K., Hitosugi, S., Wiese, E. K., Boakye-Agyeman, F., Gonsalves, W. I., Lou, Z., Karnitz, L. M., Goetz, M. P. & Hitosugi, T., Feb 6 2018, In: Cell reports. 22, 6, p. 1365-1373 9 p.
Research output: Contribution to journal › Article › peer-review
21 Scopus citations
Tyrosine Phosphorylation of Mitochondrial Creatine Kinase 1 Enhances a Druggable Tumor Energy Shuttle Pathway
Kurmi, K., Hitosugi, S., Yu, J., Boakye-Agyeman, F., Wiese, E. K., Larson, T. R., Dai, Q., Machida, Y. J., Lou, Z., Wang, L., Boughey, J. C., Kaufmann, S. H., Goetz, M. P., Karnitz, L. M. & Hitosugi, T., Dec 4 2018, In: Cell Metabolism. 28, 6, p. 833-847.e8
Research output: Contribution to journal › Article › peer-review
13 Scopus citations
A phase 1 study of the PARP inhibitor veliparib in combination with temozolomide in acute myeloid leukemia
Gojo, I., Beumer, J. H., Pratz, K. W., McDevitt, M. A., Baer, M. R., Blackford, A. L., Smith, B. D., Gore, S. D., Carraway, H. E., Showel, M. M., Levis, M. J., Dezern, A. E., Gladstone, D. E., Ji, J. J., Wang, L., Kinders, R. J., Pouquet, M., Ali-Walbi, I., Rudek, M. A., Poh, W. & 5 others, Herman, J. G., Karnitz, L. M., Kaufmann, S. H., Chen, A. & Karp, J. E., Feb 1 2017, In: Clinical Cancer Research. 23, 3, p. 697-706 10 p.
Research output: Contribution to journal › Article › peer-review
29 Scopus citations